The economic burden of asthma in the United States, 2008-2013

Annals of the American Thoracic Society

Volumn 15, Issue 3, 2018, Pages 348-356

  Nurmagambetov, Tursynbek ^a   Kuwahara, Robin ^a   Garbe, Paul ^a  

^a NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

Author keywords

Cost of illness; Health expenditures; Healthcare costs; Treatment costs

Indexed keywords

ABSENTEEISM; ADOLESCENT; ADULT; ARTICLE; ASTHMA; CHILD; COST OF ILLNESS; DISEASE BURDEN; ECONOMIC ASPECT; EDUCATIONAL STATUS; EMERGENCY WARD; ETHNIC DIFFERENCE; FEMALE; HEALTH CARE COST; HEALTH INSURANCE; HOSPITALIZATION; HUMAN; INCOME; MAJOR CLINICAL STUDY; MALE; MEDICALLY UNINSURED; MORTALITY; OUTPATIENT; POVERTY; PREVALENCE; RACE DIFFERENCE; SCHOOL ATTENDANCE; SOCIOECONOMICS; UNITED STATES; AGED; ECONOMICS; INFANT; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; TRENDS; VERY ELDERLY; YOUNG ADULT;

PRESCRIPTION DRUG;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASTHMA; CHILD; CHILD, PRESCHOOL; COST OF ILLNESS; FEMALE; HEALTH CARE COSTS; HEALTH EXPENDITURES; HOSPITALIZATION; HUMANS; INCOME; INFANT; INFANT, NEWBORN; LOGISTIC MODELS; MALE; MIDDLE AGED; PRESCRIPTION DRUGS; UNITED STATES; YOUNG ADULT;

EID: 85045242938     PISSN: 23256621     EISSN: None     Source Type: Journal    
DOI: 10.1513/AnnalsATS.201703-259OC     Document Type: Article

References (58)

1. Centers for Disease Control and Prevention, National Center for Environmental Health. Data, statistics, and surveillance: asthma surveillance data. 2016 [accessed 2016 Nov 3]. Available from: http://www.cdc.gov/asthma/asthmadata.htm.
2. Carrier E, Cunningham P. Medical cost burdens among nonelderly adults with asthma. Am J Manag Care 2014;20:925-932.
3. Dashti R, Sedighy M, Pourpak Z, Ahmadiani MS, Fazlollahi MR, Bavarian B, et al. Direct economic cost of acute asthma in emergency department. Indian J Pediatr 2013;80: 708-709.
4. Barnett SB, Nurmagambetov TA. Costs of asthma in the United States: 2002-2007. J Allergy Clin Immunol 2011;127:145-152.
5. Gergen PJ. Understanding the economic burden of asthma. J Allergy Clin Immunol 2001;107(5 Suppl):S445-S448.
6. Weiss KB, Sullivan SD. The health economics of asthma and rhinitis. I. Assessing the economic impact. J Allergy Clin Immunol 2001;107:3-8.
7. Haddix AC, Teutsch SM, Corso PS. Prevention effectiveness: a guide to decision analysis and economic evaluation. 2nd ed. New York: Oxford University Press; 2003.
8. Gold MR, Siegel JE, Russell LB, Weinstein MC, editors. Costeffectiveness in health and medicine. New York: Oxford University Press; 1996.
9. Gold M. Panel on cost-effectiveness in health and medicine. Med Care 1996;34(12 Suppl):DS197-DS199.
10. Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB. Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA 1996;276:1253-1258.
11. Russell LB, Gold MR, Siegel JE, Daniels N, Weinstein MC; Panel on Cost-Effectiveness in Health and Medicine. The role of costeffectiveness analysis in health and medicine. JAMA 1996;276: 1172-1177.
12. Weiss KB, Sullivan SD, Lyttle CS. Trends in the cost of illness for asthma in the United States, 1985-1994. J Allergy Clin Immunol 2000;106:493-499.
13. Lozano P, Sullivan SD, Smith DH, Weiss KB. The economic burden of asthma in US children: estimates from the National Medical Expenditure Survey. J Allergy Clin Immunol 1999;104:957-963.
14. Weiss KB, Sullivan SD. Socio-economic burden of asthma, allergy, and other atopic illnesses. Pediatr Allergy Immunol 1994;5(6 Suppl):7-12.
15. Weiss KB, Sullivan SD. The economic costs of asthma: a review and conceptual model. Pharmacoeconomics 1993;4:14-30.
16. Weiss KB, Gergen PJ, Hodgson TA. An economic evaluation of asthma in the United States. N Engl J Med 1992;326:862-866.
17. Lefrant JY, Garrigues B, Pribil C, Bardoulat I, Courtial F, Maurel F, et al.; CRREA Study Group; AzuRea Group. The daily cost of ICU patients: a micro-costing study in 23 French intensive care units. Anaesth Crit Care Pain Med. 2015;34:151-157.
18. Brennan A, Jackson A, Horgan M, Bergin CJ, Browne JP. Resource utilisation and cost of ambulatory HIV care in a regional HIV centre in Ireland: a micro-costing study. BMC Health Serv Res 2015;15:139.
19. Hendriks ME, Bolarinwa OA, Nelissen HE, Boers AC, Gomez GB, Tan SS, et al. Costs of cardiovascular disease prevention care and scenarios for cost saving: a micro-costing study from rural Nigeria. J Hypertens 2015;33:376-684.
20. O'Brien C, Fogarty E, Walsh C, Dempsey O, Barry M, Kennedy MJ, et al. The cost of the inpatient management of febrile neutropenia in cancer patients-a micro-costing study in the Irish healthcare setting. Eur J Cancer Care (Engl) 2015;24:125-132.
21. Parkinson F, Kent SJ, Aldous C, Oosthuizen G, Clarke D. The hospital cost of road traffic accidents at a South African regional trauma centre: a micro-costing study. Injury 2014;45:342-345.
22. McLaughlin AM, Hardt J, Canavan JB, Donnelly MB. Determining the economic cost of ICU treatment: a prospective "micro-costing" study. Intensive Care Med 2009;35:2135-2140.
23. Gold MR. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996.
24. Manning WG, Basu A, Mullahy J. Generalized modeling approaches to risk adjustment of skewed outcomes data. J Health Econ 2005;24:465-488.
25. Manning WG, Mullahy J. Estimating log models: to transform or not to transform? J Health Econ 2001;20:461-494.
26. Kamble S, Bharmal M. Incremental direct expenditure of treating asthma in the United States. J Asthma 2009;46:73-80.
27. Sullivan PW, Ghushchyan VH, Slejko JF, Belozeroff V, Globe DR, Lin SL. The burden of adult asthma in the United States: evidence from the Medical Expenditure Panel Survey. J Allergy Clin Immunol 2011;127:363-369.e3.
28. Agency for Healthcare Research and Quality (AHRQ). Medical expenditure panel survey. Rockville, MD: AHRQ [accessed 2017 Aug 1]. Available from: https://meps.ahrq.gov/mepsweb/.
29. Centers for Disease Control and Prevention, National Center for Health Statistics. National Health Interview Survey. Hyattsville, MD: National Center for Health Statistics [accessed 2016 Jul 15]. Available from: http://www.cdc.gov/nchs/nhis/.
30. StataCorp. Stata: data analysis and statistical software. College Station, TX: StataCorp [accessed 2017 Nov 1]. Available from: http://www.stata.com/.
31. U.S. Department of Labor, Bureau of Labor Statistics. Washington, DC: U.S. Department of Labor, Bureau of Labor Statistics [accessed 2016 Nov 15]. Available from: http://www.bls.gov/home.htm.
32. Belotti F, Deb P, Manning WG, Norton EC. twopm: two-part models. Stata J 2015;15:3-20.
33. D'Hoore W, Bouckaert A, Tilquin C. Practical considerations on the use of the Charlson comorbidity index with administrative data bases. J Clin Epidemiol 1996;49:1429-1433.
34. Weisbrod BA. Economics of public health: measuring the impact of diseases. Philadelphia: University of Pennsylvania Press: 1961.
35. Jonsson B. Measuring economic burden in asthma. In: Weiss KB, Buist AS, Sullivan SD, editors. Asthma's impact on society: the social and economic burden. New York: Marcel Dekker; 2000. pp. 251-267.
36. Centers for Disease Control and Prevention. CDC WONDER. Atlanta, GA: Centers for Disease Control and Prevention [accessed 2017 Nov 1]. Available from: http://wonder.cdc.gov/wonder/help/aboutcdc-wonder-508.pdf.
37. Robinson LA, Hammitt JK. Valuing reduction in fatal illness risks: implications of recent research. Health Econ 2016;25:1039-1052.
38. Jang J, Gary Chan KC, Huang H, Sullivan SD. Trends in cost and outcomes among adult and pediatric patients with asthma: 2000-2009. Ann Allergy Asthma Immunol 2013;111:516-522.
39. Bui AL, Dieleman JL, Hamavid H, Birger M, Chapin A, Duber HC, et al. Spending on children's personal health care in the United States, 1996-2013. JAMA Pediatr 2017;171:181-189.
40. Nurmagambetov T, Khavjou O, Murphy L, Orenstein D. State-level medical and absenteeism cost of asthma in the United States. J Asthma 2017;54:357-370.
41. Wang LY, Zhong Y, Wheeler L. Direct and indirect costs of asthma in school-age children. Prev Chronic Dis 2005;2(1). Available from: http://www.cdc.gov/pcd/issues/2005/jan/04-0053.htm.
42. Landefeld JS, Seskin EP. The economic value of life: linking theory to practice. Am J Public Health 1982;72:555-566.
43. Rappaport H, Bothapally V. The direct expenditures and indirect costs associated with treating asthma in the United States. J Allergy Ther 2012;3:1000118.
44. Sullivan PW, Ghushchyan V, Navaratnam P, Friedman HS, Kavati A, Ortiz B, et al. The national cost of asthma among school-aged children in the United States. Ann Allergy Asthma Immunol 2017;119: 246-252.e1.
45. Sullivan PW, Ghushchyan VH, Navaratnam P, Friedman HS, Kavati A, Ortiz B, et al. National prevalence of poor asthma control and associated outcomes among school-aged children in the United States. J Allergy Clin Immunol Pract [online ahead of print] 25 Aug 2017; DOI: 10.1016/j.jaip.2017.06.039.
46. Sullivan PW, Ghushchyan VG, Navaratnam P, Friedman HS, Kavati A, Ortiz B, et al. School absence and productivity outcomes associated with childhood asthma in the USA. J Asthma [online ahead of print] 25 Apr 2017; DOI: 10.1080/02770903.2017.1313273.
47. Akinbami LJ, Moorman JE, Bailey C, Zahran HS, King M, Johnson CA, et al. Trends in asthma prevalence, health care use, and mortality in the United States, 2001-2010. NCHS Data Brief 2012;(94).
48. Aligne CA, Auinger P, Byrd RS, Weitzman M. Risk factors for pediatric asthma: contributions of poverty, race, and urban residence. Am J Respir Crit Care Med 2000;162:873-877.
49. Krieger JW. Home is where the triggers are: increasing asthma control by improving the home environment. Pediatr Allergy Immunol Pulmonol 2010;23:139-145.
50. Krieger JW, Song L, Takaro TK, Stout J. Asthma and the home environment of low-income urban children: preliminary findings from the Seattle-King County healthy homes project. J Urban Health 2000; 77:50-67.
51. Alhanti BA, Chang HH, Winquist A, Mulholland JA, Darrow LA, Sarnat SE. Ambient air pollution and emergency department visits for asthma: a multi-city assessment of effect modification by age. J Expo Sci Environ Epidemiol 2016;26:180-188.
52. Kattan M, Stearns SC, Crain EF, Stout JW, Gergen PJ, Evans R III, et al. Cost-effectiveness of a home-based environmental intervention for inner-city children with asthma. J Allergy Clin Immunol 2005;116: 1058-1063.
53. Sullivan SD, Weiss KB, Lynn H, Mitchell H, Kattan M, Gergen PJ, et al.; National Cooperative Inner-City Asthma Study (NCICAS) Investigators. The cost-effectiveness of an inner-city asthma intervention for children. J Allergy Clin Immunol 2002;110:576-581.
54. Pearlman DN, Zierler S, Meersman S, Kim HK, Viner-Brown SI, Caron C. Race disparities in childhood asthma: does where you live matter? J Natl Med Assoc 2006;98:239-247.
55. Akinbami LJ, Moorman JE, Garbe PL, Sondik EJ. Status of childhood asthma in the United States, 1980-2007. Pediatrics 2009;123(Suppl 3):S131-S145.
56. Ortega AN, Gergen PJ, Paltiel AD, Bauchner H, Belanger KD, Leaderer BP. Impact of site of care, race, and Hispanic ethnicity on medication use for childhood asthma. Pediatrics 2002;109:E1.
57. Le TT, Bilderback A, Bender B, Wamboldt FS, Turner CF, Rand CS, et al. Do asthma medication beliefs mediate the relationship between minority status and adherence to therapy? J Asthma 2008;45:33-37.
58. Gottlieb DJ, Beiser AS, O'Connor GT. Poverty, race, and medication use are correlates of asthma hospitalization rates: a small area analysis in Boston. Chest 1995;108:28-35.